Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238981 (US9403833, 16) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238975 (US9403833, 10 | US9403833, 12) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238975 (US9403833, 10 | US9403833, 12) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 98 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238979 (US9403833, 14) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238966 (US9403833, 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238970 (US9403833, 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238967 (US9403833, 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 570 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238968 (US9403833, 3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 890 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238976 (US9403833, 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238969 (US9403833, 4) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238973 (US9403833, 8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238982 (US9403833, 17) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238978 (US9403833, 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238974 (US9403833, 9) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.40E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238980 (US9403833, 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238972 (US9403833, 7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
E3 ubiquitin-protein ligase SMURF1 [420-757] (Homo sapiens (Human)) | BDBM238971 (US9403833, 6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Novartis AG US Patent | Assay Description For the biochemical assay panel, 50 nl of the test compounds, reference compounds and buffer/DMSO control are transferred to the respective wells of ... | US Patent US9403833 (2016) BindingDB Entry DOI: 10.7270/Q2PN94JM | |||||||||||
More data for this Ligand-Target Pair |